We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two clinical investigators and a sponsor of device trials received FDA warning letters in three separate and unrelated inspections involving failure to carry out required procedures, inadequate recordkeeping and reporting failures.